Matches in Nanopublications for { ?s ?p "[The mTOR pathway is an important therapeutic target in vascular tumors, and topical mTOR inhibitors may provide an alternative and well-tolerated therapy for the treatment of cutaneous vascular lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP566539.RAXlNsstHGHoVkNFc2E5uz4VOJ0q6S9spMdn8OStxTzGE130_assertion description "[The mTOR pathway is an important therapeutic target in vascular tumors, and topical mTOR inhibitors may provide an alternative and well-tolerated therapy for the treatment of cutaneous vascular lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP566539.RAXlNsstHGHoVkNFc2E5uz4VOJ0q6S9spMdn8OStxTzGE130_provenance.
- assertion description "[The mTOR pathway is an important therapeutic target in vascular tumors, and topical mTOR inhibitors may provide an alternative and well-tolerated therapy for the treatment of cutaneous vascular lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The mTOR pathway is an important therapeutic target in vascular tumors, and topical mTOR inhibitors may provide an alternative and well-tolerated therapy for the treatment of cutaneous vascular lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP412107.RAVpJMTqGzGzeYPf85jNEOKsm0pbv3PZ_bxYm6NlKuj2Y130_assertion description "[The mTOR pathway is an important therapeutic target in vascular tumors, and topical mTOR inhibitors may provide an alternative and well-tolerated therapy for the treatment of cutaneous vascular lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP412107.RAVpJMTqGzGzeYPf85jNEOKsm0pbv3PZ_bxYm6NlKuj2Y130_provenance.
- NP1101820.RAYWMwUWYv-kCJ24hYUbeLR-le4W4ZStn6lPwQjxIofNE130_assertion description "[The mTOR pathway is an important therapeutic target in vascular tumors, and topical mTOR inhibitors may provide an alternative and well-tolerated therapy for the treatment of cutaneous vascular lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1101820.RAYWMwUWYv-kCJ24hYUbeLR-le4W4ZStn6lPwQjxIofNE130_provenance.
- NP412287.RAAtAJWL7TZ7mDzzDRXbOjWx1UAtGcbtbkcCA5XNbsxiA130_assertion description "[The mTOR pathway is an important therapeutic target in vascular tumors, and topical mTOR inhibitors may provide an alternative and well-tolerated therapy for the treatment of cutaneous vascular lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP412287.RAAtAJWL7TZ7mDzzDRXbOjWx1UAtGcbtbkcCA5XNbsxiA130_provenance.
- NP1101825.RAjj64H7_xkJHTJtlQdkb7CqcVdvpNIm0GnQGP4DruZJ8130_assertion description "[The mTOR pathway is an important therapeutic target in vascular tumors, and topical mTOR inhibitors may provide an alternative and well-tolerated therapy for the treatment of cutaneous vascular lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1101825.RAjj64H7_xkJHTJtlQdkb7CqcVdvpNIm0GnQGP4DruZJ8130_provenance.